153 related articles for article (PubMed ID: 16886593)
1. Combination growth hormone and gonadotropin releasing hormone analog therapy in 11beta-hydroxylase deficiency.
Bajpai A; Kabra M; Menon PS
J Pediatr Endocrinol Metab; 2006 Jun; 19(6):855-7. PubMed ID: 16886593
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
[TBL] [Abstract][Full Text] [Related]
3. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
Lanes R; Soros A; Jakubowicz S
J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
[TBL] [Abstract][Full Text] [Related]
4. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group.
Oostdijk W; Drop SL; Odink RJ; Hümmelink R; Partsch CJ; Sippell WG
Acta Paediatr Scand Suppl; 1991; 372():39-45; discussion 46. PubMed ID: 1833950
[TBL] [Abstract][Full Text] [Related]
5. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
Quintos JB; Vogiatzi MG; Harbison MD; New MI
J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
[TBL] [Abstract][Full Text] [Related]
7. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
8. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
Cara JF; Kreiter ML; Rosenfield RL
J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
[TBL] [Abstract][Full Text] [Related]
9. Restoration of Height after 11 Years of Letrozole Treatment in 11β-Hydroxylase Deficiency.
Atay Z; Turan S; Buğdaycı O; Guran T; Bereket A
Horm Res Paediatr; 2019; 92(3):203-208. PubMed ID: 31454824
[TBL] [Abstract][Full Text] [Related]
10. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
Lanes R; Gunczler P
Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty.
Brauner R; Malandry F; Rappaport R
Eur J Pediatr; 1992 Oct; 151(10):728-30. PubMed ID: 1425790
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
[TBL] [Abstract][Full Text] [Related]
13. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
14. GH and GnRH analog treatment in children who enter puberty at short stature.
Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Hibi I
J Pediatr Endocrinol Metab; 1997; 10(6):623-8. PubMed ID: 9467133
[TBL] [Abstract][Full Text] [Related]
15. [Improvement of expected and final height in girls with central precocious puberty treated with gonadotropin releasing hormone analogues].
Gómez F; Picó AM; Vargas F; Mauri M
Med Clin (Barc); 1996 Nov; 107(18):681-4. PubMed ID: 9082075
[TBL] [Abstract][Full Text] [Related]
16. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
[TBL] [Abstract][Full Text] [Related]
17. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
18. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
Kohn B; Julius JR; Blethen SL
Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
[TBL] [Abstract][Full Text] [Related]
19. Growth promotion by oxandrolone in a girl with short stature and early pubertal development treated with growth hormone and gonadotropin-releasing hormone-analogue. A case study.
Hermanussen M
Acta Paediatr; 1995 Oct; 84(10):1207-10. PubMed ID: 8563241
[TBL] [Abstract][Full Text] [Related]
20. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]